Pallas Capital Advisors LLC Has $1.31 Million Stock Holdings in Cigna Group $CI

Pallas Capital Advisors LLC raised its position in Cigna Group (NYSE:CI) by 133.1% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 4,774 shares of the health services provider’s stock after acquiring an additional 2,726 shares during the period. Pallas Capital Advisors LLC’s holdings in Cigna Group were worth $1,314,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in CI. Dodge & Cox raised its holdings in shares of Cigna Group by 4.0% in the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after purchasing an additional 354,615 shares during the last quarter. Sanders Capital LLC boosted its holdings in Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after purchasing an additional 35,150 shares during the last quarter. Capital Research Global Investors boosted its holdings in Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after purchasing an additional 1,855,897 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in Cigna Group by 7.4% in the third quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider’s stock valued at $777,012,000 after purchasing an additional 186,880 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its position in Cigna Group by 54.5% in the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after purchasing an additional 753,865 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on CI shares. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Guggenheim restated a “buy” rating and issued a $318.00 price objective on shares of Cigna Group in a report on Monday, February 2nd. Sanford C. Bernstein raised Cigna Group from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $307.00 to $358.00 in a research report on Thursday, March 12th. Mizuho set a $325.00 target price on Cigna Group in a report on Friday, January 9th. Finally, Piper Sandler reduced their price target on Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $333.11.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company’s stock.

Cigna Group Stock Performance

Shares of CI stock opened at $261.98 on Monday. The stock has a market cap of $69.04 billion, a P/E ratio of 11.81, a P/E/G ratio of 0.91 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The company has a fifty day moving average price of $277.10 and a two-hundred day moving average price of $280.16. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were paid a $1.56 dividend. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.4%. The ex-dividend date was Thursday, March 5th. Cigna Group’s dividend payout ratio is currently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.